跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,395 条关于
“GSK'990”
全部
4,395
临床试验
2,116
药物
1,504
机构
29
资讯
746
2年前
GSK Acquires Boston Pharmaceuticals' Efimosfermin for Liver Disease in $2 Billion Deal
去年
GSK Acquires Efimosfermin for $1.2 Billion to Target Steatotic Liver Disease
2年前
GSK Licenses Hansoh Pharma's B7-H3 ADC, HS-20093, for $185 Million Upfront
9年前
GSK's GSK5764227 Receives FDA Breakthrough Therapy Designation for Osteosarcoma
去年
GSK's B7-H3-Targeted ADC, GSK'227, Receives FDA Breakthrough Therapy Designation for Osteosarcoma
去年
Oxford and GSK Launch £50 Million Program to Develop Cancer Prevention Vaccine
去年
FDA Revokes Authorization of GSK and Vir's Sotrovimab Due to BA.2 Inefficacy
去年
GSK's Daprodustat Shows Positive Phase III Results for Nasal Polyps
去年
GSK's Cancer Portfolio Gains Momentum with Regulatory Successes for Dostarlimab and GSK'227
去年
GSK's GSK'227 Receives FDA Breakthrough Therapy Designation for Relapsed Osteosarcoma
第 1 页,共 75 页
上一页
下一页